Page 4 - Clinj Am Soc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial

Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHiddo heerspinkBrendan mcevoySharon barrChelsea fordAstrazeneca pharmaceuticalsUniversity medical center groningenDepartment of clinical pharmacyNational kidney foundationUniversity of groningenClinical pharmacyExecutive vice presidentRare diseasesInt supplChronic kidney disease

Novartis Pharma AG: Novartis investigational atrasentan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)

Novartis Pharma AG: Novartis investigational atrasentan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMichael meoNicole zinsli sommIhre chancenMarlena abdinoorIndiens wirtschaftRichard jarvisJonathan grahamLambers heerspinkSatoshi sugimotoSamir shahParag mahantiSloan simpsonZain iqbalShreeram aradhyeImke kappes

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United statesParag mahantiSatoshi sugimotoSamir shahRichard jarvisMichael meoNicole zinsli sommMarlena abdinoorSloan simpsonIsabella zinckJulie masowShreeram aradhyeNovartis biomedical researchExchange commissionEuropean medicines agencyNovartis pharmaceuticals

Real-world evidence study shows the significant impact of hyperkalaemia on cardiorenal patient outcomes

Real-world evidence study shows the significant impact of hyperkalaemia on cardiorenal patient outcomes
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomSanjay rastogiColl cardiolCompany on twitterDiabetes work groupInvestor relations teamEuropean renal associationClinical chiefExecutive vice presidentBiopharmaceuticals business unitRare diseaseObservational studyCardiorenal patientsNat revDialysate potassium concentrationsClinj am soc

The Impact of a Clinical Pharmacist on Immunosuppressive Medication Adherence in Kidney Transplant Patients

Studies show that patients who had pharmacists as part of their transplant-related care had a significant improvement in clinical outcomes.

United statesIndianj urolDmitriy kandinskiyNational institute of diabetesNational kidney foundationNational kidneyPublished augustDisease statisticsPublished septemberTerm immunosuppression managementClinj am socAdv chronic